Single Rising Dose Study to Assess Safety, Tolerability and Pharmacokinetics of BI 661051.
Clinical trial NCT01343719 · COMPLETED
Trial details
- NCT number
- NCT01343719
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-04-01
- Primary completion
- 2011-07-01
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.